Market Place
Sourcing Support
Bausch, Teva Accused of Delaying Generic Xifaxan
23 Sep 2025 //
REUTERS
Supreme Court Declines Patent Dispute Over Bausch Diarrhea Drug
18 Nov 2024 //
REUTERS
Court Blocks Norwich`s ANDA Approval Until 2029
11 Apr 2024 //
ACCESSWIRE
Bausch Health Responds to Norwich`s ANDA Tentative Approval
06 Jun 2023 //
ACCESSWIRE
Pressure on generic drugmakers increases with new price fixing lawsuit
10 Jun 2020 //
BIOPHARMADIVE
Morton Grove`s Withdrawal of Approval of 21 Abbreviated New Drug Applications
02 Dec 2019 //
FEDERALREGISTER
False claims suits pose new patent challenge pathway
21 Aug 2019 //
POLITICO
Perrigo Announces Patent Litigation Settlement for Generic Version of Jublia
14 Feb 2019 //
PR NEWSWIRE
Gentamicin : Flow Pharma vs. Valeant Pharma
30 Jan 2019 //
PATENT LITIGATION
Uceris (budesonide) : Valeant Pharmaceuticals, Salix Pharmaceuticals vs. Sun Pharmaceutical Industries
13 Dec 2018 //
PATENT LITIGATION
Narcan (naloxone hydrochloride) : Adapt Pharma vs. Perrigo UK
20 Nov 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Mylan
02 Oct 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. KVK-Tech
02 Oct 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken vs. Amneal Pharma
02 Oct 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Cipla Ltd.
25 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Acrux DDS Pty Ltd.
25 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Perrigo Pharma
24 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Apotex Corp.
24 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Macleods Pharma
24 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole): Valeant Pharma, Dow Pharma, Kaken v. Aleor Dermaceutical
22 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) :Valeant Pharmaceuticals vs. Teva Pharma USA
22 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Aurobindo Pharma
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Strides Pharma
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma v. Alkem Labs
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma v. Lupin
15 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharmac v. Par Pharmaceutical
11 Sep 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken Pharma vs. Zydus Pharma
07 Sep 2018 //
PATENT LITIGATION
Uceris (budesonide) : Valeant Pharmaceuticals et al v. Teva Pharmaceuticals et al
27 Aug 2018 //
PATENT LITIGATION
Generic-Drug Companies to Face First Charges in U.S. Probe
24 Apr 2018 //
BLOOMBERG
Limited competition for Pfizer generic drives launch rejig
14 Mar 2018 //
IN PHARMATECHNOLOGIST
Outrage as teva charges $18,275 for generic drug in us
27 Feb 2018 //
JPOST
World`s Largest Generic Drug Maker Seeks Tie Up With Producer of Chinese Viagra
07 Nov 2017 //
REUTERS
FDA`s generic competition push hits Valeant`s Isuprel, a price-hike poster child
08 Aug 2017 //
FIERCE PHARMA
Valeant could be hit hardest by FDA generics push: analyst
28 Jun 2017 //
FIERCE PHARMA
Lupin receives FDA approval for generic Wellbutrin XL Tablets
10 Apr 2017 //
INDIAN INFOLINE
Senate proposes incentivizing generic drugmakers to help control price hikes
21 Dec 2016 //
FIERCE PHARMA
Valeant, Horizon, et al.: Payers, patients target pricey meds that combo cheap generics
01 Nov 2016 //
FIERCE PHARMA
Drugmakers Turn Cheap Generics Into Expensive Pills
31 Oct 2016 //
WALL STREET
Valeant`s still raising prices on long-generic Wellbutrin XL. Who`s paying up?
19 Oct 2016 //
FIERCE PHARMA
Valeant Pharmaceuticals Announces Relaunch Of Generic Ofloxacin Otic Solution
08 Aug 2016 //
PR NEWSWIRE
Republicans Scrutinize FDA`s Vouchers, Generic Drug Approvals
15 Dec 2015 //
BLOOMBERG
Perrigo Announce FDA Approval and Launch AB Rated Generic Version of BenzaClin®
22 Sep 2015 //
PR NEWS WIRE
